Aiwai'er

Shenzhen Aiwai'er Hospital Management Group Co., Ltd. (hereinafter referred to as "Aiwai'er Hospital Group") was established under the personal guidance and care of Professor Zhang Lizhu, known as the "Mother of IVF in China." It has focused on the field of human assisted reproduction for 25 years. With human assisted reproductive technology at its core, it covers upstream and downstream sectors, including infertility, obstetrics and gynecology, pregnancy maintenance, postpartum rehabilitation, traditional Chinese medicine, and integrated medicine, forming a professional reproductive chain hospital group. Aiwai'er Hospital Group owns multiple medical entities, including Zhanjiang Jiuhe Hospital, Jieyang Aiwai'er Hospital, Tianjin Aiwei Hospital, and Kunming Aiwai'er Hospital.
In international cooperation, Aiwai'er Hospital Group maintains close exchanges with institutions such as the Stanford University Reproductive Center in the United States, Kato Ladies Clinic in Japan, and the Sydney IVF Center in Australia, keeping its technical level consistently aligned with the international frontier. It has successively introduced advanced diagnostic and treatment technologies into clinical application, including vitrification, mini-stimulation and natural cycle therapy, in vitro ovarian activation (IVA), and endometrial receptivity analysis (ERA), ensuring a steady increase in clinical pregnancy rates. In 2015, it founded the "IVF International Forum," which has been successfully held for three consecutive sessions and has become an annual event in reproductive medicine, playing an important role in promoting academic exchange within the industry and driving industry development.
Aiwai'er Hospital Group unswervingly devotes itself to the field of human assisted reproductive technology, operates in compliance with the law, and sincerely serves patients, with the goal of "helping patients have their own baby as soon as possible." While bringing hope of childbirth to numerous infertile families, Aiwai'er Hospital Group spares no effort in moving toward becoming a social enterprise, operating lawfully, balancing public welfare, and courageously assuming social responsibility. It actively donates money and goods to vulnerable groups, provides disaster relief and educational assistance, and reduces or waives medical expenses for patients from financially disadvantaged families, having invested tens of millions of yuan in social public welfare undertakings cumulatively. On January 23, 2013, at the "2012 (Second) China Public Welfare Festival" held in Beijing, Aiwai'er Hospital Group was awarded the "Annual Project Award and Collective Award."
Based in China and with an international perspective, Aiwai'er Hospital Group's future vision is to "become a leading force in global reproductive medicine and a respected enterprise." It is committed to the application, research, and dissemination of high-level reproductive medicine technology, bringing joy and happiness to more infertile families and contributing to the health and well-being of all humanity. Creating life and delivering happiness is the unswerving pursuit of Aiwai'er Hospital Group!